Get insights from Ligand Pharmaceuticals' Q2 2025 earnings—57% royalty revenue growth, raised guidance, and key partnerships driving long-term growth.

Watsco (WSO) stock offers a defensive investment with dividends. Read why investors should look at this steady HVAC company.

Discover how Elanco Animal Health exceeded revenue and EPS expectations in Q2 2025, raised guidance, and accelerated innovation-driven growth.

Discover key insights from EPAM Systems' Q2 2025 earnings call: double-digit growth, raised outlook, AI-driven transformation, and a seamless CEO transition.

Standard Lithium has innovative extraction technology, strategic partnerships, and zero-debt structure. Click for more on SLI ...

Discover Evergy's Q2 2025 earnings insights, with strong operational results, growth projections, and an expanding customer pipeline driving ...

Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

Euroseas is deeply undervalued, trading at a deep discount to NAV and future revenues. The company’s multi-year charters provide stable, predictable revenue and shield against spot market volatility.

Gain insights into Take-Two Interactive's stellar Q1 2026 performance, raised net bookings outlook, and robust growth in NBA 2K, GTA, and mobile franchises.

Gilead Sciences, Inc.'s HIV dominance with Biktarvy & Yeztugo boosts revenue potential. Click for more about GILD and its ...

Discover Tripadvisor's Q2 2025 performance: 7% revenue growth, AI-driven innovations, and strategic synergies fuel gains at Viator & TheFork.